CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile

CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
67 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

CombiMatrix Corporation (CombiMatrix) is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNA-based testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Oligo Arrays with single nucleotide polymorphism (SNPs) and Oligo Arrays with SNPs for formalin-fixed, paraffin-embedded (FFPE) tissue.

CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on

  
Source:
Document ID
GDME16017D
Country
Industry
Ticker
CBMX=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
CombiMatrix Corporation, Medical Equipment, Deals By Year, 2010 to YTD 201652
CombiMatrix Corporation, Medical Equipment Deals By Type, 2010 to YTD 201671
CombiMatrix Corporation, Medical Equipment, Deals By Region, 2010 to YTD 201681
CombiMatrix Corporation, Medical Equipment, Deals By Market, 2010 to YTD 201691
CombiMatrix Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016101
CombiMatrix Corporation, Medical Equipment, Deal Details1120
  Partnerships111
    CombiMatrix Enters Into Licensing Agreement With Cartagenia For Benchlab CNV Platform111
    CombiMatrix Enters into Distribution Agreement with Universal Diagnostic Labs121
    Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing131
    CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests141
    CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests151
    CombiMatrix Enters Into An Agreement With Clarient161
  Equity Offering171
    CombiMatrix Raises USD8 Million in Public Offering of Units172
    CombiMatrix to Raise USD5 Million in Private Placement of Securities192
    CombiMatrix to Raise USD3 Million in Private Placement of Warrants212
    CombiMatrix Completes Public Offering Of Units For US$12 Million232
    CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million251
    CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million261
    CombiMatrix Completes Private Placement Of Units For US$1.6 Million271
    CombiMatrix Completes Second Tranche Of Private Placement Of Series A Shares Of Preferred Stock281
    CombiMatrix Completes Private Placement Of Units For US$7 Million292
CombiMatrix Corporation - Key Competitors311
Key Employees321
Locations And Subsidiaries331
  Head Office331
  Other Locations &Subsidiaries331
Recent Developments341
Strategy And Business Planning341
Apr 21, 2016: CombiMatrix Provides Strategic Update341
Financial Announcements351
Aug 03, 2016: CombiMatrix Reports Second Quarter 2016 Financial and Operating Results352
May 04, 2016: CombiMatrix Reports First Quarter 2016 Financial and Operating Results372
Feb 17, 2016: CombiMatrix Reports 2015 Fourth Quarter and Full Year Financial and Operating Results392
Nov 04, 2015: CombiMatrix Corporation Reports Third Quarter 2015 Financial and Operating Results412
Aug 04, 2015: CombiMatrix Reports Second Quarter 2015 Financial and Operating Results432
May 07, 2015: CombiMatrix Reports First Quarter 2015 Financial and Operating Results452
Feb 25, 2015: CombiMatrix Reports Fourth Quarter and Full Year 2014 Financial and Operating Results472
Corporate Communications491
Feb 26, 2016: CombiMatrix Forms Scientific Advisory Board; Includes Leaders in Reproductive Health, Pathology, Genetics, Molecular Biology and Health Policy491
Feb 17, 2016: CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement501
Feb 11, 2016: CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss511
Jun 25, 2015: CombiMatrix Expands Sales Team to Accelerate Entry Into New Markets521
Mar 16, 2015: CombiMatrix Appoints Lale White to Board of Directors531
Jan 20, 2015: CombiMatrix Names Karen Warner, RN, Vice President of Reimbursement541
Legal and Regulatory551
Apr 28, 2015: CombiMatrix Executes Final Settlement Ending Litigation551
Mar 12, 2015: Superior Court Issues Final Statement of Decision and Enters Judgment in Favor of CombiMatrix561
Jan 06, 2015: Superior Court Issues Tentative Ruling and Proposed Statement of Decision in Favor of CombiMatrix571
Government and Public Interest581
Dec 11, 2015: CombiMatrix Highlights Two Recent Developments581
Product News591
Feb 09, 2016: CombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel591
Feb 01, 2016: CombiMatrix Study Published in Genetics in Medicine601
Jan 28, 2016: CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis611
Apr 10, 2015: New England Journal of Medicine Article Supports Importance of Follow-up Diagnostic Testing Following Positive Noninvasive Prenatal Screening Test621
Other Significant Developments631
Mar 23, 2016: ACOG and SMFM Update Practice Bulletins Recommending Prenatal Genetic Assessment for All Pregnant Women Regardless of Age or Other Risk Factors631
Feb 11, 2016: CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss641
Dec 16, 2015: CombiMatrix Announces Multicycle Offering for Pre-Implantation Genetic Screening and Improved Cost Efficiencies651
Mar 19, 2015: CombiMatrix Announces Payor Contract With InterWest Health661
Appendix671
  Methodology671
  About GlobalData671
  Contact Us671
  Disclaimer671

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/CombiMatrix-Corporation-CBMX-Medical-Equipment-Deals-and-Alliances-Profile-2148-5550>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). CombiMatrix Corporation (CBMX) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/CombiMatrix-Corporation-CBMX-Medical-Equipment-Deals-and-Alliances-Profile-2148-5550>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research